Mitzi Nagarkatti to Cannabinoid Receptor Antagonists
This is a "connection" page, showing publications Mitzi Nagarkatti has written about Cannabinoid Receptor Antagonists.
Connection Strength
0.282
-
Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity. Sci Rep. 2017 11 15; 7(1):15645.
Score: 0.149
-
Cannabinoids as novel anti-inflammatory drugs. Future Med Chem. 2009 Oct; 1(7):1333-49.
Score: 0.085
-
Perinatal exposure to ?9-tetrahydrocannabinol triggers profound defects in T cell differentiation and function in fetal and postnatal stages of life, including decreased responsiveness to HIV antigens. J Pharmacol Exp Ther. 2011 Nov; 339(2):607-17.
Score: 0.024
-
Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: evidence from an experimental murine model. J Pharmacol Exp Ther. 2011 Sep; 338(3):819-28.
Score: 0.024